参考文献/References:
[1] World Health Organization. Obesity and overweight: fact sheet N°311[EB/OL].
http://www.who.int/mediacentre/factsheets/fs311/en/2015.3.7.
[2] Ng M, Fleming T, Robinson M,et al. Global, regional, and national prevalence of overweight
and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden
of Disease Study 2013[J].Lancet,2014,384(9945):766-781.DOI: 10.1016/S0140-6736(14)60460-8.
[3] Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-
alpha: direct role in obesity-linked insulin resistance[J].Science,1993,259(5091):87-91.
[4] Wang Y, Huang F. N-3 polyunsaturated fatty acids and inflammation in obesity: local effect
and systemic benefit[J]. Biomed Res Int,2015,2015:581469. DOI: 10.1155/2015/581469.
[5] Cao H. Adipocytokines in obesity and metabolic disease[J].J Endocrinol,2014,220(2):T47-T59.
DOI: 10.1530/JOE-13-0339.
[6] Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolic disease[J].Cell
Metab,2011,13(1):11-22. DOI: 10.1016/j.cmet.2010.12.008.
[7] Wang XA, Zhang R, She ZG,et al. Interferon regulatory factor 3 constrains IKKβ/NF-κB
signaling to alleviate hepatic steatosis and insulin resistance[J].Hepatology,2014,59(3):870-
885. DOI: 10.1002/hep.26751.
[8] Maury E, Noël L, Detry R,et al. In vitro hyperresponsiveness to tumor necrosis
factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects[J].J
Clin Endocrinol Metab,2009,94(4):1393-1400.DOI:10.1210/jc.2008-2196.
[9] Pendyala S, Neff LM, Suárez-Fariñas M,et al. Diet-induced weight loss reduces
colorectal inflammation: implications for colorectal carcinogenesis[J].Am J Clin Nutr,2011,93
(2):234-242. DOI: 10.3945/ajcn.110.002683.
[10] Trussardi Fayh AP, Lopes AL, Fernandes PR, et al. Impact of weight loss with or without
exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical
trial[J].Br J Nutr,2013,110(3):486-492. DOI: 10.1017/S0007114512005442.
[11] Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and
intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes[J].J
Nutr, 2015, 145(1):177S-183S. DOI: 10.3945/jn.114.195065.
[12] Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and
role in human disease[J].Biochim Biophys Acta,2007,1773(8):1341-1348.
[13] Han MS, Jung DY, Morel C,et al. JNK expression by macrophages promotes obesity-induced
insulin resistance and inflammation[J].Science,2013,339(6116):218-222.
DOI:10.1126/science.1227568.
[14] Khan S, Wang CH. ER stress in adipocytes and insulin resistance: mechanisms and
significance(Review)[J].Mol Med Rep,2014,10(5):2234-2240.DOI:10.3892/mmr.2014.2532.
[15] Dong H, Huang H, Yun X,et al. Bilirubin increases insulin sensitivity in leptin-receptor
deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation
[J].Endocrinology,2014,155(3):818-828.DOI: 10.1210/en.2013-1667.
[16] Nishimura S, Manabe I, Nagasaki M,et al. In vivo imaging in mice reveals local cell
dynamics and inflammation in obese adipose tissue[J].J Clin Invest,2008,118(2):710-721. DOI:
10.1172/JCI33328.
[17] Piya MK, Harte AL, McTernan PG. Metabolic endotoxaemia: is it more than just a gut feeling
[J].Curr Opin Lipidol,2013,24(1):78-85. DOI: 10.1097/MOL.0b013e32835b4431.
[18] Leuwer M, Welters I, Marx G,et al. Endotoxaemia leads to major increases in inflammatory
adipokine gene expression in white adipose tissue of mice[J].Pflugers Arch,2009,457(4):731-
741.DOI: 10.1007/s00424-008-0564-8.
[19] Ridaura VK, Faith JJ, Rey FE,et al. Gut microbiota from twins discordant for obesity
modulate metabolism in mice[J].Science,2013,341(6150):1241214.DOI: 10.1126/science.1241214.
[20] Nguyen MT, Favelyukis S, Nguyen AK,et al. A subpopulation of macrophages infiltrates
hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4
and JNK-dependent pathways[J].J Biol Chem,2007,282(48):35279-35292.
[21] Akash MS, Shen Q, Rehman K,et al. Interleukin-1 receptor antagonist: a new therapy for type
2 diabetes mellitus[J]. J Pharm Sci,2012,101(5):1647-1658. DOI: 10.1002/jps.23057.
相似文献/References:
[1]刘美娟,朱惠娟,龚凤英.Glypican-，4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity，insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(05):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
[2]张立弋,常宝成,单春艳,等.SIRT1与糖尿病相关肿瘤的关系[J].国际内分泌代谢杂志,2017,37(06):418.
Zhang Liyi,Chang Baocheng,Shan Chunyan,et al.Association of SIRT1 with diabetes-related tumors[J].International Journal of Endocrinology and Metabolism,2017,37(05):418.
[3]张娴 陈宏.新型脂肪因子与肥胖相关代谢性疾病[J].国际内分泌代谢杂志,2018,38(03):171.[doi:10.3760/cma.j.issn.1673-4157.2018.03.007]
Zhang Xian,Chen Hong.Novel adipokines and obesity-related metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(05):171.[doi:10.3760/cma.j.issn.1673-4157.2018.03.007]
[4]丘如,黄贵心.血炎性指标NLR、PLR及MHR与糖尿病性
心肌病的相关性研究[J].国际内分泌代谢杂志,2020,40(06):367.[doi:10.3760/cma.j.cn121383-20200301-03060]
Qiu Ru,Huang Guixin.Study on the correlation between blood inflammatory indexes NLR, PLR, MHR and diabetic cardiomyopathy[J].International Journal of Endocrinology and Metabolism,2020,40(05):367.[doi:10.3760/cma.j.cn121383-20200301-03060]
[5]胡雯婧,朱惠娟,龚凤英.脂肪组织衰老与肥胖症关系的研究进展[J].国际内分泌代谢杂志,2023,43(06):492.[doi:10.3760/cma.j.cn121383-20220910-09019]
Hu Wenjing,Zhu Huijuan,Gong Fengying..Research progress of adipose tissue senescence and obesity[J].International Journal of Endocrinology and Metabolism,2023,43(05):492.[doi:10.3760/cma.j.cn121383-20220910-09019]